EYES Annual CFF
$75.62 M
+$67.02 M+779.46%
31 December 2021
Summary:
As of February 5, 2025, EYES annual cash flow from financing activities is $75.62 million, with the most recent change of +$67.02 million (+779.46%) on December 31, 2021. During the last 3 years, it has risen by +$49.02 million (+184.26%).EYES Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Quarterly CFF
$0.00
$0.000.00%
30 June 2022
Summary:
As of February 5, 2025, EYES quarterly cash flow from financing activities is $0.00, unchanged on June 30, 2022. Over the past year, it has dropped by -$51.15 million (-100.00%).EYES Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES TTM CFF
$2000.00
-$51.15 M-100.00%
30 June 2022
Summary:
As of February 5, 2025, EYES TTM cash flow from financing activities is $2000.00, with the most recent change of -$51.15 million (-100.00%) on June 30, 2022. Over the past year, it has dropped by -$77.81 million (-100.00%).EYES TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYES Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +779.5% | -100.0% | -100.0% |
| 3 y3 years | +184.3% | -100.0% | -100.0% |
| 5 y5 years | +257.2% | -100.0% | -100.0% |
EYES Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -100.0% | -100.0% |
Second Sight Medical Products Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $0.00(0.0%) | $2000.00(-100.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $51.15 M(-32.4%) |
| Dec 2021 | $75.62 M(+779.5%) | $2000.00(>+9900.0%) | $75.62 M(-2.8%) |
| Sept 2021 | - | $0.00(-100.0%) | $77.81 M(0.0%) |
| June 2021 | - | $51.15 M(+109.1%) | $77.81 M(+135.3%) |
| Mar 2021 | - | $24.47 M(+1012.1%) | $33.07 M(+284.6%) |
| Dec 2020 | $8.60 M(-75.4%) | $2.20 M(>+9900.0%) | $8.60 M(+27.4%) |
| Sept 2020 | - | $0.00(-100.0%) | $6.75 M(0.0%) |
| June 2020 | - | $6.40 M(<-9900.0%) | $6.75 M(+1053.8%) |
| Mar 2020 | - | -$5000.00(-101.4%) | $585.00 K(-98.3%) |
| Dec 2019 | $34.99 M(+31.5%) | $352.00 K(>+9900.0%) | $34.99 M(-16.5%) |
| Sept 2019 | - | $0.00(-100.0%) | $41.88 M(-10.6%) |
| June 2019 | - | $238.00 K(-99.3%) | $46.85 M(-17.8%) |
| Mar 2019 | - | $34.40 M(+374.8%) | $56.99 M(+114.3%) |
| Dec 2018 | $26.60 M(+25.7%) | $7.25 M(+45.8%) | $26.60 M(+28.8%) |
| Sept 2018 | - | $4.97 M(-52.1%) | $20.64 M(+31.7%) |
| June 2018 | - | $10.38 M(+159.0%) | $15.68 M(+185.8%) |
| Mar 2018 | - | $4.01 M(+210.9%) | $5.49 M(-74.1%) |
| Dec 2017 | $21.17 M | $1.29 M(>+9900.0%) | $21.17 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $1000.00(-99.5%) | $20.03 M(+0.0%) |
| June 2017 | - | $189.00 K(-99.0%) | $20.03 M(-49.6%) |
| Mar 2017 | - | $19.69 M(>+9900.0%) | $39.75 M(+94.4%) |
| Dec 2016 | $20.45 M(+641.3%) | $153.00 K(>+9900.0%) | $20.45 M(-1.2%) |
| Sept 2016 | - | $0.00(-100.0%) | $20.71 M(-0.9%) |
| June 2016 | - | $19.91 M(+5045.2%) | $20.90 M(+631.4%) |
| Mar 2016 | - | $387.00 K(-4.9%) | $2.86 M(+3.6%) |
| Dec 2015 | $2.76 M(-93.7%) | $407.00 K(+106.6%) | $2.76 M(-92.5%) |
| Sept 2015 | - | $197.00 K(-89.4%) | $36.58 M(-3.7%) |
| June 2015 | - | $1.87 M(+548.3%) | $37.97 M(-12.5%) |
| Mar 2015 | - | $288.00 K(-99.2%) | $43.39 M(-0.9%) |
| Dec 2014 | $43.80 M(+99.3%) | $34.23 M(+2053.3%) | $43.80 M(+212.1%) |
| Sept 2014 | - | $1.59 M(-78.2%) | $14.04 M(-7.7%) |
| June 2014 | - | $7.28 M(+935.4%) | $15.21 M(-6.8%) |
| Mar 2014 | - | $703.50 K(-84.2%) | $16.31 M(-25.8%) |
| Dec 2013 | $21.97 M(+22.2%) | $4.46 M(+61.4%) | $21.97 M(+25.5%) |
| Sept 2013 | - | $2.76 M(-67.1%) | $17.51 M(+18.7%) |
| June 2013 | - | $8.39 M(+31.7%) | $14.75 M(+131.7%) |
| Mar 2013 | - | $6.37 M | $6.37 M |
| Dec 2012 | $17.98 M | - | - |
FAQ
- What is Second Sight Medical Products annual cash flow from financing activities?
- What is the all time high annual CFF for Second Sight Medical Products?
- What is Second Sight Medical Products annual CFF year-on-year change?
- What is Second Sight Medical Products quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Second Sight Medical Products?
- What is Second Sight Medical Products quarterly CFF year-on-year change?
- What is Second Sight Medical Products TTM cash flow from financing activities?
- What is the all time high TTM CFF for Second Sight Medical Products?
- What is Second Sight Medical Products TTM CFF year-on-year change?
What is Second Sight Medical Products annual cash flow from financing activities?
The current annual CFF of EYES is $75.62 M
What is the all time high annual CFF for Second Sight Medical Products?
Second Sight Medical Products all-time high annual cash flow from financing activities is $75.62 M
What is Second Sight Medical Products annual CFF year-on-year change?
Over the past year, EYES annual cash flow from financing activities has changed by +$67.02 M (+779.46%)
What is Second Sight Medical Products quarterly cash flow from financing activities?
The current quarterly CFF of EYES is $0.00
What is the all time high quarterly CFF for Second Sight Medical Products?
Second Sight Medical Products all-time high quarterly cash flow from financing activities is $51.15 M
What is Second Sight Medical Products quarterly CFF year-on-year change?
Over the past year, EYES quarterly cash flow from financing activities has changed by -$51.15 M (-100.00%)
What is Second Sight Medical Products TTM cash flow from financing activities?
The current TTM CFF of EYES is $2000.00
What is the all time high TTM CFF for Second Sight Medical Products?
Second Sight Medical Products all-time high TTM cash flow from financing activities is $77.81 M
What is Second Sight Medical Products TTM CFF year-on-year change?
Over the past year, EYES TTM cash flow from financing activities has changed by -$77.81 M (-100.00%)